BeyondSpring Inc. Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share
BeyondSpring Inc. (BYSI) reported Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare · last filed 2026-08-14
- BeyondSpring Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2026-06-30 was $0.00.
- BeyondSpring Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- BeyondSpring Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-06-30 was $0.00.
- BeyondSpring Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for the quarter ending 2025-03-31 was $0.17.
- BeyondSpring Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2024 was -$0.07.
- BeyondSpring Inc. discontinued operation, income (loss) from discontinued operation, net of tax, per basic share for fiscal 2023 was -$0.20.
| Period end | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 3 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 6 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 9 month | Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.18 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $0.17 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$0.07 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | -$0.07 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.03 10-Q · filed 2025-08-13 | -$0.07 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$0.03 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$0.20 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |